Quick Answer
INSMED Inc reported Revenue From Contract With Customer Excluding Assessed Tax of $606.42 million for the year ending 2025.
- INSMED Inc showed an increase of +66.7% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from INSMED Inc's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $0.00 | Q2 2017: $0.00 | Q3 2017: $0.00 | Q4 2017: $0.00 | Q1 2018: $0.00 | Q2 2018: $0.00 | Q3 2018: $0.00 | Q4 2018: $9.84 million | Q1 2019: $21.90 million | Q2 2019: $29.97 million | Q3 2019: $38.89 million | Q4 2019: $45.71 million | Q1 2020: $36.86 million | Q2 2020: $42.50 million | Q3 2020: $43.64 million | Q1 2021: $40.21 million | Q2 2021: $45.37 million | Q3 2021: $46.76 million | Q1 2022: $53.11 million | Q2 2022: $65.22 million | Q3 2022: $67.73 million | Q1 2023: $65.21 million | Q2 2023: $77.23 million | Q3 2023: $79.07 million | Q1 2024: $75.50 million | Q2 2024: $90.34 million | Q3 2024: $93.43 million | Q1 2025: $92.82 million | Q2 2025: $107.42 million | Q3 2025: $142.34 million.
- Historical annual values: Fiscal year 2025: $606.42 million | Fiscal year 2024: $363.71 million | Fiscal year 2023: $305.21 million | Fiscal year 2022: $245.36 million | Fiscal year 2021: $188.46 million | Fiscal year 2020: $164.41 million | Fiscal year 2019: $136.47 million | Fiscal year 2018: $9.84 million | Fiscal year 2017: $0.00 | Fiscal year 2016: $0.00.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: